Sfoglia per Autore
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients
2018-01-01 Schirripa, Marta; Zhang, Wu; Yang, Dongyun; Cao, Shu; Okazaki, Satoshi; Loupakis, Fotios; Berger, Martin D; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Alberti, Giulia; West, Jordan D; Lonardi, Sara; Khoukaz, Taline; Bergamo, Francesca; Battaglin, Francesca; Antoniotti, Carlotta; Falcone, Alfredo; Stintzing, Sebastian; Heinemann, Volker; Lenz, Heinz-Josef
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
2018-01-01 Dell'Aquila, E; Cremolini, C; Zeppola, T; Lonardi, S; Bergamo, F; Masi, G; Stellato, M; Marmorino, F; Schirripa, M; Urbano, F; Ronzoni, M; Tomasello, G; Zaniboni, A; Racca, P; Buonadonna, A; Allegrini, G; Fea, E; Di Donato, S; Chiara, S; Tonini, G; Tomcikova, D; Boni, L; Falcone, A; Santini, D
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer
2018-01-01 Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Cremolini, Chiara; Lonardi, Sara; Bergamo, Francesca; Ning, Yang; Yamamoto, Noriko; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Yamaguchi, Toshiharu; Stintzing, Sebastian; Heinemann, Volker; Loupakis, Fotios; Falcone, Alfredo; Lenz, Heinz-Josef
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study
2018-01-01 Schirripa, Marta; Pasqualetti, Giuseppe; Giampieri, Riccardo; Scartozzi, Mario; Lonardi, Sara; Rumanò, Laura; Bergamo, Francesca; Stragliotto, Silvia; Murgioni, Sabina; Alberti, Giulia; Rizzato, Mario Domenico; Prete, Alessandra Anna; Puzzoni, Marco; Pusceddu, Valeria; Ziranu, Pina; Pani, Fabiana; Mariotti, Stefano; Zagonel, Vittorina; Monzani, Fabio; Loupakis, Fotios
Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study
2018-01-01 Hanna, Diana L; Loupakis, Fotios; Yang, Dongyun; Cremolini, Chiara; Schirripa, Marta; Li, Meng; Matsusaka, Satoshi; Berger, Martin D; Miyamoto, Yuji; Zhang, Wu; Ning, Yan; Antoniotti, Carlotta; Salvatore, Lisa; Moran, Miriana; Zeger, Gary; Astrow, Stephanie H; Falcone, Alfredo; Lenz, Heinz-Josef
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib
2018-01-01 Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Cremolini, Chiara; Antoniotti, Carlotta; Borelli, Beatrice; Mashima, Tetsuo; Okazaki, Satoshi; Berger, Martin D; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Lonardi, Sara; Yamaguchi, Toshiharu; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: A clinical and molecular proof of concept study
2019-01-01 Cremolini, Chiara; Benelli, Matteo; Fontana, Elisa; Pagani, Filippo; Rossini, Daniele; Fucà, Giovanni; Busico, Adele; Conca, Elena; Di Donato, Samantha; Loupakis, Fotios; Schirripa, Marta; Lonardi, Sara; Borelli, Beatrice; Ongaro, Elena; Eason, Katherine; Morano, Federica; Casagrande, Mariaelena; Fassan, Matteo; Sadanandam, Anguraj; De Braud, Filippo; Falcone, Alfredo; Pietrantonio, Filippo
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial
2019-01-01 Cremolini, C; Marmorino, F; Bergamo, F; Aprile, G; Salvatore, L; Masi, G; Dell'Aquila, E; Antoniotti, C; Murgioni, S; Allegrini, G; Borelli, B; Gemma, D; Casagrande, M; Granetto, C; Delfanti, S; Di Donato, S; Schirripa, M; Sensi, E; Tonini, G; Lonardi, S; Fontanini, G; Boni, L; Falcone, A.
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
2019-01-01 Schirripa, Marta; Borelli, Beatrice; D'Aurizio, Romina; Lubrano, Simone; Cremolini, Chiara; Zucchelli, Gemma; Antoniotti, Carlotta; Marmorino, Federica; Prete, Alessandra Anna; Murgioni, Sabina; Bergamo, Francesca; Zagonel, Vittorina; Tuccoli, Andrea; Marranci, Andrea; Rizzo, Milena; Tedeschi, Lorena; Magnoni, Letizia; Falcone, Alfredo; Loupakis, Fotios; Poliseno, Laura
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
2019-01-01 Del Re, Marzia; Cinieri, Saverio; Michelucci, Angela; Salvadori, Stefano; Loupakis, Fotios; Schirripa, Marta; Cremolini, Chiara; Crucitta, Stefania; Barbara, Cecilia; Di Leo, Angelo; Latiano, Tiziana Pia; Pietrantonio, Filippo; Di Donato, Samantha; Simi, Paolo; Passardi, Alessandro; De Braud, Filippo; Altavilla, Giuseppe; Zamagni, Claudio; Bordonaro, Roberto; Butera, Alfredo; Maiello, Evaristo; Pinto, Carmine; Falcone, Alfredo; Mazzotti, Valentina; Morganti, Riccardo; Danesi, Romano
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer
2020-01-01 Fanelli, G. N.; Dal Pozzo, C. A.; Depetris, I.; Schirripa, M.; Brignola, S.; Biason, P.; Balistreri, M.; Dal Santo, L.; Lonardi, S.; Munari, G.; Loupakis, F.; Fassan, M.
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial
2020-01-01 Pasqualetti, G.; Schirripa, M.; Dochy, E.; Fassan, M.; Ziranu, P.; Puzzoni, M.; Scartozzi, M.; Alberti, G.; Lonardi, S.; Zagonel, V.; Monzani, F.; Loupakis, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients | 1-gen-2018 | Schirripa, Marta; Zhang, Wu; Yang, Dongyun; Cao, Shu; Okazaki, Satoshi; Loupakis, Fotios; Berger, Martin D; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Alberti, Giulia; West, Jordan D; Lonardi, Sara; Khoukaz, Taline; Bergamo, Francesca; Battaglin, Francesca; Antoniotti, Carlotta; Falcone, Alfredo; Stintzing, Sebastian; Heinemann, Volker; Lenz, Heinz-Josef | |
| Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO | 1-gen-2018 | Dell'Aquila, E; Cremolini, C; Zeppola, T; Lonardi, S; Bergamo, F; Masi, G; Stellato, M; Marmorino, F; Schirripa, M; Urbano, F; Ronzoni, M; Tomasello, G; Zaniboni, A; Racca, P; Buonadonna, A; Allegrini, G; Fea, E; Di Donato, S; Chiara, S; Tonini, G; Tomcikova, D; Boni, L; Falcone, A; Santini, D | |
| Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer | 1-gen-2018 | Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Cremolini, Chiara; Lonardi, Sara; Bergamo, Francesca; Ning, Yang; Yamamoto, Noriko; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Yamaguchi, Toshiharu; Stintzing, Sebastian; Heinemann, Volker; Loupakis, Fotios; Falcone, Alfredo; Lenz, Heinz-Josef | |
| Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study | 1-gen-2018 | Schirripa, Marta; Pasqualetti, Giuseppe; Giampieri, Riccardo; Scartozzi, Mario; Lonardi, Sara; Rumanò, Laura; Bergamo, Francesca; Stragliotto, Silvia; Murgioni, Sabina; Alberti, Giulia; Rizzato, Mario Domenico; Prete, Alessandra Anna; Puzzoni, Marco; Pusceddu, Valeria; Ziranu, Pina; Pani, Fabiana; Mariotti, Stefano; Zagonel, Vittorina; Monzani, Fabio; Loupakis, Fotios | |
| Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study | 1-gen-2018 | Hanna, Diana L; Loupakis, Fotios; Yang, Dongyun; Cremolini, Chiara; Schirripa, Marta; Li, Meng; Matsusaka, Satoshi; Berger, Martin D; Miyamoto, Yuji; Zhang, Wu; Ning, Yan; Antoniotti, Carlotta; Salvatore, Lisa; Moran, Miriana; Zeger, Gary; Astrow, Stephanie H; Falcone, Alfredo; Lenz, Heinz-Josef | |
| Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib | 1-gen-2018 | Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Cremolini, Chiara; Antoniotti, Carlotta; Borelli, Beatrice; Mashima, Tetsuo; Okazaki, Satoshi; Berger, Martin D; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Lonardi, Sara; Yamaguchi, Toshiharu; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef | |
| Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: A clinical and molecular proof of concept study | 1-gen-2019 | Cremolini, Chiara; Benelli, Matteo; Fontana, Elisa; Pagani, Filippo; Rossini, Daniele; Fucà, Giovanni; Busico, Adele; Conca, Elena; Di Donato, Samantha; Loupakis, Fotios; Schirripa, Marta; Lonardi, Sara; Borelli, Beatrice; Ongaro, Elena; Eason, Katherine; Morano, Federica; Casagrande, Mariaelena; Fassan, Matteo; Sadanandam, Anguraj; De Braud, Filippo; Falcone, Alfredo; Pietrantonio, Filippo | |
| Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial | 1-gen-2019 | Cremolini, C; Marmorino, F; Bergamo, F; Aprile, G; Salvatore, L; Masi, G; Dell'Aquila, E; Antoniotti, C; Murgioni, S; Allegrini, G; Borelli, B; Gemma, D; Casagrande, M; Granetto, C; Delfanti, S; Di Donato, S; Schirripa, M; Sensi, E; Tonini, G; Lonardi, S; Fontanini, G; Boni, L; Falcone, A. | |
| Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib | 1-gen-2019 | Schirripa, Marta; Borelli, Beatrice; D'Aurizio, Romina; Lubrano, Simone; Cremolini, Chiara; Zucchelli, Gemma; Antoniotti, Carlotta; Marmorino, Federica; Prete, Alessandra Anna; Murgioni, Sabina; Bergamo, Francesca; Zagonel, Vittorina; Tuccoli, Andrea; Marranci, Andrea; Rizzo, Milena; Tedeschi, Lorena; Magnoni, Letizia; Falcone, Alfredo; Loupakis, Fotios; Poliseno, Laura | |
| DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients | 1-gen-2019 | Del Re, Marzia; Cinieri, Saverio; Michelucci, Angela; Salvadori, Stefano; Loupakis, Fotios; Schirripa, Marta; Cremolini, Chiara; Crucitta, Stefania; Barbara, Cecilia; Di Leo, Angelo; Latiano, Tiziana Pia; Pietrantonio, Filippo; Di Donato, Samantha; Simi, Paolo; Passardi, Alessandro; De Braud, Filippo; Altavilla, Giuseppe; Zamagni, Claudio; Bordonaro, Roberto; Butera, Alfredo; Maiello, Evaristo; Pinto, Carmine; Falcone, Alfredo; Mazzotti, Valentina; Morganti, Riccardo; Danesi, Romano | |
| The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | 1-gen-2020 | Fanelli, G. N.; Dal Pozzo, C. A.; Depetris, I.; Schirripa, M.; Brignola, S.; Biason, P.; Balistreri, M.; Dal Santo, L.; Lonardi, S.; Munari, G.; Loupakis, F.; Fassan, M. | |
| Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial | 1-gen-2020 | Pasqualetti, G.; Schirripa, M.; Dochy, E.; Fassan, M.; Ziranu, P.; Puzzoni, M.; Scartozzi, M.; Alberti, G.; Lonardi, S.; Zagonel, V.; Monzani, F.; Loupakis, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile